"Revenue -- $15.2 million for the quarter, representing an increase of 3% driven by higher national advertising funding. Adjusted EBITDA -- $3.6 million for the quarter, up 7.8%; $13 million full year, rising 13.9% compared to 2024. Net Income -- $1 million for the quarter; $2.9 million for the year, reversing a $5.8 million loss in 2024."
"Refranchising Progress -- Reduced company-owned clinics from 135 to 48, with 27 clinics under sale agreements or letters of intent; nearly all remaining clinics are in California. Clinic Network -- Total clinic count at year-end was 960, composed of 885 franchise clinics and 75 company-owned clinics, after opening 29, refranchising 41, and closing 36 locations."
"2026 Guidance -- System-wide sales projected at $540 million-$552 million, comp sales expected in the range of negative 3% to positive 3%, and consolidated adjusted EBITDA anticipated at $12.5 million-$13.5 million. Year-end clinic count expected to decline as closures offset new openings during portfolio reshaping."
The company reported $15.2 million in quarterly revenue, up 3% from national advertising funding increases, while system-wide sales declined 3.9% to $140 million for the quarter. Comparable sales decreased 3.8% quarterly and 0.4% annually. Adjusted EBITDA improved 7.8% quarterly to $3.6 million and 13.9% annually to $13 million. Net income reversed prior losses, reaching $2.9 million for the year. The refranchising strategy significantly reduced company-owned clinics from 135 to 48, with 27 under sale agreements. The clinic network totaled 960 locations at year-end. Marketing shifted to national advertising and SEO, showing sequential monthly improvement in new patient acquisition. The company repurchased 1.3 million shares for $11.3 million and maintained $23.6 million in unrestricted cash with no credit line draws.
#financial-performance #refranchising-strategy #clinic-network-optimization #profitability-improvement #2026-guidance
Read at The Motley Fool
Unable to calculate read time
Collection
[
|
...
]